medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2023, Number 02

<< Back Next >>

Ginecol Obstet Mex 2023; 91 (02)

Cost of early removal of family planning methods

Martínez-Hernández YI, Villarreal-Ríos E, Galicia-Rodríguez L, Cu-Flores LA

Language: Spanish
References: 14
Page: 62-99
PDF size: 186.00 Kb.


ABSTRACT

Objective: To determine the cost of early removal of family planning methods.
Materials and Methods: Cost study realized in records of women users of family planning method in a health institution in Querétaro, Mexico from 2018 to 2021. The unit of observation was considered to be the records of women who had early removal of the copper IUD, Mirena IUD and subdermal implant methods. Early removal was defined as the retirement of the method before the estimated time of use. Work was done with the total number of records (1361), with early removal in 148 (83 copper IUDs, 28 Mirena IUDs, 37 subdermal implants). The entire population was included, so no sampling technique was used. The cost of early removal was identified from the unit cost of the method, expected time of use, time of non-use. The statistical analysis plan included averages, percentages, confidence intervals and projections for which assumptions were used.
Results: The unit cost of early removal of copper IUD was $5.59 (95% CI; 5.04-6.14), Mirena IUD $1210.73 (95% CI; 1029.58 - 1391.87) Subdermal implant $658.41 (95% CI; 557.37- 759.44). The projection to the Mexican population of the cost of early removal of family planning methods is $359, 384,161.
Conclusiones: The cost of early removal of family planning methods is high.


REFERENCES

  1. Organización Mundial de la Salud. Anticoncepción. https://www.who.int/es/health-topics/contraception#tab=tab_1

  2. Norma Oficial Mexicana, NOM 005- SSA2- 1993, De losservicios de Planificación Familiar, 1993. http://www.salud.gob.mx/unidades/cdi/nom/005ssa23.html.

  3. Soto-Blanco F, Delgado-Martín AE, Becerra-Martínez ML,Guillamón-Sánchez M, et al. DIU en atención primaria.Med Integral 2003; 41 (3): 162-69. https://www.elsevier.es/es-revista-medicina-integral-63-pdf-13046291

  4. Organización Mundial de la Salud. Planificación familiar:un manual para proveedores, 2019. http://apps.who.int/iris/bitstream/10665/44074/1/9780978856304_spa.pdf

  5. Lopez-Olmos J. Dispositivo intrauterino liberador de levonorgestrel(DiuM®) y miomas. Efectos clínicos. Clin InvestGin Obst 2016; 43 (4): 164-73. https://doi.org/10.1016/j.gine.2015.05.003

  6. Araya-Calvo PI, Chacón-Díaz S,Palzano Venega G. Implantesubdérmico. Revisión bibliográfica. Revista Ciencia y SaludIntegrando Conocimientos 2021; 5 (4): 29-34. https://doi.org/10.34192/cienciaysalud.v5i3.293

  7. Gómez-Leal DC, Zabala-Muñoz DA. Motivos de retiroanticipado de métodos de anticoncepción con implantesSubdérmicos Jadelle® e Implanon Nxt® por grupos deedad (Trabajo de investigación para optar al título deEspecialista en Epidemiología) Bogotá 2018. https://doi.org/10.48713/10336_18376

  8. Barrera-Coello L, Olvera-Rodríguez V, Castelo-Branco C,Cancelo-Hidalgo MJ. Causas de desapego a los métodosanticonceptivos. Ginecol Obstet Mex 2020; 88 (1): 88-95.https://doi.org/10.24245/gom.v88iSupl1.3853

  9. Morgan-Ortiz F, Morgan-Ruiz F, Báez-Barraza J, QuevedoCastro. Dismenorrea: una revisión. Rev Med UAS 2015; 5(1). https://hospital.uas.edu.mx/revmeduas/pdf/v5/n1/dismenorrea.pdf

  10. Acosta-León O, De-la-Cruz-López K, Rodríguez-Columbié C.Efectos adversos del implante anticonceptivo subdérmicoen adolescentes. Revista Cubana de Medicina Militar 2019;48 (3). http://www.revmedmilitar.sld.cu/index.php/mil/article/view/308

  11. Berni-Clebsch R, Taboada-Wagener D, Gibert W, Benitez-Roa Z. 5 años de Experiencia en la utilización del dispositivointrauterino liberador de levonorgestrel. Rev Salud PúblicaParag 2012; 2 (2): 18-26. https://docs.bvsalud.org/biblioref/2018/11/965427/18-26.pdf

  12. Frutos-Balibrea MI, Sánchez-Núñez EJ, Pedrero-Pérez A,Haro-León MT, Benítez-Robredo. Métodos anticonceptivosde larga duración en mujeres menores de 26 años, Medicinade Familia. SEMERGEN, 2021; 47 (7): 457-64. https://doi.org/10.1016/j.semerg.2021.04.010

  13. Instituto Nacional de Geografía e Informática. 2020.https://www.inegi.org.mx/temas/estructura/

  14. Instituto Nacional de Geografía e Informática. 2018.https://www.inegi.org.mx/app/indicadores/?ind=6200112351&tm=7#D6200112351




2020     |     www.medigraphic.com